Latest stories

  • in

    NPPA Revises Ceiling Price of 233 Scheduled Formulation, Details

    New Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) increase of 12.1218%, through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India has revised and fixed the ceiling price of 233 scheduled formulations under the Drug (Price Control) […] More

  • in

    Sandoz gets European Commission nod for Hyrimoz high-concentration formulation

    Basel: Sandoz has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for a citrate-free high concentration formulation (HCF; 100 mg/mL) of its biosimilar Hyrimoz (adalimumab). The approval includes all indications covered by the reference medicine*: rheumatic diseases, Crohn’s disease, ulcerative colitis, plaque psoriasis, uveitis and hidradenitis suppurativa. “Living […] More